* Zura Bio Ltd ZURA.OQ ZURA.O is expected to report
resultson
May 6 (estimated) for the period ending March 31 2024
*
* LSEG's mean analyst estimate for Zura Bio Ltd is for a
loss
of 23 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Zura Bio
Ltd is
$18.00, above its last closing price of $4.62.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.23 -0.19 Beat 17.5
Sep. 30 2023 -0.25 -0.25 -0.18 Beat 27.4
Jun. 30 2023 -0.23 -0.25 -1.31 Missed -431.1
This summary was machine generated May 4 at 02:26 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)